The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study.

Tuccinardi DarioGiorgino RiccardoPieralice SilviaWatanabe MikikoMaggi DariaPalermo AndreaDefeudis GiuseppeFioriti ElviraPozzilli PaoloManfrini Silvia

Published in: Acta diabetologica (2020)

Insulin-treated patients with long-standing T2D showed detectable level of fasting C-peptide. Measuring the β-cell function may therefore guide toward effective therapeutic options when oral hypoglycemic agents prove unsuccessful.

Keyphrases

type diabetes
glycemic control
insulin resistance
blood glucose
cardiovascular disease
physical activity
risk factors
newly diagnosed
blood pressure
weight loss